Skip secondary menu

2nd iPSC Participant List


2nd iPSC Consortia Workshop

December 15, 2010
Hyatt Regency
Bethesda, Maryland
Workshop    Agenda    Executive Summary

 

PARTICIPANT LIST

Sergey Akimov, Ph.D.
Johns Hopkins University

Nicholas Allen, Ph.D.
University of Cardiff

Jamshid Arjomand, Ph.D.
CHDI Foundation, Inc.

Laurie Arrants, M.S.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Andrea Baruchin, Ph.D.
Foundation for the National Institutes of Health

Virginia Barrett-Mattis, Ph.D.
Cedars-Sinai Medical Center

James Beck, Ph.D.
Parkinson’s Disease Foundation

Robi Blumenstein
CHDI Foundation

Lucie Bruijn, Ph.D.
Amyotrophic Lateral Sclerosis Association

Elena Cattaneo, Ph.D.
University of Milan

Kenneth Vielsted Christensen, Ph.D., M.Sc.
Lundbeck

Laura Cole, Ph.D.
National Institute on Deafness and Other Communication Disorders
National Institutes of Health

Amy Comstock Rick, J.D.
Parkinson’s Action Network

Oliver Cooper, Ph.D.
McLean Hospital, a Harvard Medical School Affiliate

Jeff Dage, Ph.D.
Eli Lilly and Company

Ted Dawson, M.D., Ph.D.
Johns Hopkins University

Francesco Di Giorgio
Novartis

Susan Dickinson, M.S.
Association for Frontotemporal Dementias

John Dunlop, Ph.D.
Pfizer

Roxanne Duan, Ph.D.
GlaxoSmithKline

Meredith Estess
Project A.L.S.

Valerie Estess
Project A.L.S.

Jian Feng, Ph.D.
State University of New York at Buffalo

Steve Finkbeiner, M.D., Ph.D.
University of California, San Francisco

Kenneth Fischbeck, M.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Brian Fiske, Ph.D.
Michael J. Fox Foundation for Parkinson’s Research

Wendy Galpern, M.D., Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Philip Gregory, D.Phil.
Sangamo BioSciences, Inc.

Amelie Gubitz, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Heather Gunas, J.D., M.P.H.
National Cancer Institute
National Institutes of Health

Jim Gusella, Ph.D.
Massachusetts General Hospital

Katrina Gwinn, M.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Chris Henderson, Ph.D.
Columbia University

Ole Isacson, M.D., Ph.D.
Harvard Medical School

Julia Kaye, Ph.D.
University of California, San Francisco

Margaret Keller, Ph.D.
Coriell Institute for Medical Research

Paul Kemp, D.Phil.
University of Cardiff

Kwang-Soo Kim, Ph.D.
McLean Hospital, a Harvard Medical School Affiliate

Alvin King, Ph.D.
University of California, Irvine

Evangelos Kiskinis
Harvard University

Walter Koroshetz, M.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Dimitri Krainc, M.D., Ph.D.
Massachusetts General Hospital

Story Landis, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Timothy LaVaute, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Virginia Lee, Ph.D.
University of Pennsylvania

Ying Li, Ph.D.
Johns Hopkins University

Leslie Lock, Ph.D.
University of California, Irvine

Marcy MacDonald, Ph.D.
Massachusetts General Hospital

Laura Mamounas, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Thomas Maniatis, Ph.D.
Columbia University Medical Center

Katerina Markopoulou, M.D., Ph.D.
Mayo Clinic Jacksonville

Ian Martin, Ph.D.
Johns Hopkins University

Kalpana Merchant, Ph.D.
Eli Lilly and Company

Branka Mitrovic, M.D.
Vertex

Jung-Il Moon, Ph.D.
McLean Hospital, a Harvard Medical School Affiliate

Marco Onorati, Ph.D.
University of Milan

David Owens, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

David Panchision, Ph.D.
National Institute of Mental Health
National Institutes of Health

Serge Przedborski, M.D., Ph.D.
Columbia University

Shanta Rajaram, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Michele Rankin, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Robert Riddle, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Chris Ross, M.D., Ph.D.
Johns Hopkins University

Owen Ross, Ph.D.
Mayo Clinic Jacksonville

Jeffrey Rothstein, M.D., Ph.D.
Robert Packard Center for ALS Research at Johns Hopkins

Erik Runko, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

David Rushton
Cardiff University

Matt Self, M.S.
Coriell Institute for Medical Research

Beth-Anne Sieber, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Randy Singh, Ph.D.
Massachusetts General Hospital

Berta Strulovici, Ph.D.
iPierian

Jim Surmeier, Ph.D.
Northwestern University

Margaret Sutherland, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Clive Svendsen, Ph.D.
Cedars-Sinai Medical Center

Danilo Tagle, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Fred Taubman
Huntington’s Disease Society of America

Anna Taylor, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Leslie Thompson, Ph.D.
University of California, Irvine

Christine Torborg, Ph.D.
National Institutes of Health

David Weiner, M.D.
EMD-Serono

Nancy Wexler, Ph.D.
Herediatry Disease Foundation

Christopher Wiessner, Ph.D.
Merck Serono

Alan Willard, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Sara Winokur, Ph.D.
University of California, Irvine

Julie Wolf-Rodda
Foundation for the National Institutes of Health

Buck Wong
National Institute on Deafness and Other Communication Disorders
National Institutes of Health

Zbigniew Wszolek, M.D.
Mayo Clinic Jacksonville

Ran Zhang, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Zhong Zhong, Ph.D.
GlaxoSmithKline

Last updated December 23, 2013